Net profit of RPG Life Sciences declined 36.64% to Rs 22.13 crore in the quarter ended December 2025 as against Rs 34.93 crore during the previous quarter ended December 2024. Sales rose 4.24% to Rs 180.03 crore in the quarter ended December 2025 as against Rs 172.71 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales180.03172.71 4 OPM %22.0928.46 - PBDT42.9252.35 -18 PBT37.5446.89 -20 NP22.1334.93 -37 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 27 January 2026.Powered by Capital Market - Live News

Net profit of RPG Life Sciences rose 777.38% to Rs 36.85 crore in the quarter ended September 2025 as against Rs 4.20 crore during the previous quarter ended September 2024. Sales rose 5.50% to Rs 181.68 crore in the quarter ended September 2025 as against Rs 172.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales181.68172.21 5 OPM %21.4826.67 - PBDT43.4547.70 -9 PBT38.2342.39 -10 NP36.854.20 777 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 17 October 2025.Powered by Capital Market - Live News

Net profit of RPG Life Sciences declined 1.76% to Rs 26.29 crore in the quarter ended June 2025 as against Rs 26.76 crore during the previous quarter ended June 2024. Sales rose 2.12% to Rs 168.92 crore in the quarter ended June 2025 as against Rs 165.42 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales168.92165.42 2 OPM %21.0023.62 - PBDT40.5741.29 -2 PBT35.4336.00 -2 NP26.2926.76 -2 Powered by Capital Market - Live News